- Home
- HUDI vs ATHA Comparison
HUDI vs ATHA Comparison
Compare HUDI & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUDI
- ATHA
- Stock Information
- Founded
- HUDI 2018
- ATHA 2011
- Country
- HUDI China
- ATHA United States
- Employees
- HUDI N/A
- ATHA N/A
- Industry
- HUDI Steel/Iron Ore
- ATHA Medicinal Chemicals and Botanical Products
- Sector
- HUDI Industrials
- ATHA Health Care
- Exchange
- HUDI Nasdaq
- ATHA Nasdaq
- Market Cap
- HUDI 18.8M
- ATHA 21.0M
- IPO Year
- HUDI 2021
- ATHA 2020
- Fundamental
- Price
- HUDI $1.49
- ATHA $0.26
- Analyst Decision
- HUDI
- ATHA Buy
- Analyst Count
- HUDI 0
- ATHA 4
- Target Price
- HUDI N/A
- ATHA $11.25
- AVG Volume (30 Days)
- HUDI 13.6K
- ATHA 214.5K
- Earning Date
- HUDI 05-23-2025
- ATHA 05-09-2025
- Dividend Yield
- HUDI N/A
- ATHA N/A
- EPS Growth
- HUDI N/A
- ATHA N/A
- EPS
- HUDI 0.01
- ATHA N/A
- Revenue
- HUDI $74,270,429.00
- ATHA N/A
- Revenue This Year
- HUDI N/A
- ATHA N/A
- Revenue Next Year
- HUDI N/A
- ATHA N/A
- P/E Ratio
- HUDI $156.78
- ATHA N/A
- Revenue Growth
- HUDI N/A
- ATHA N/A
- 52 Week Low
- HUDI $1.27
- ATHA $0.22
- 52 Week High
- HUDI $3.45
- ATHA $3.67
- Technical
- Relative Strength Index (RSI)
- HUDI 55.55
- ATHA 45.40
- Support Level
- HUDI $1.36
- ATHA $0.23
- Resistance Level
- HUDI $1.51
- ATHA $0.30
- Average True Range (ATR)
- HUDI 0.13
- ATHA 0.03
- MACD
- HUDI 0.02
- ATHA 0.00
- Stochastic Oscillator
- HUDI 85.19
- ATHA 37.12
About HUDI Huadi International Group Co. Ltd.
Huadi International Group Co Ltd is a manufacturer of industrial stainless steel seamless pipes and tubes products. Its products are used in the oil & gas transmission, chemistry engineering, food processing, medical devices, aeronautics and astronautics, boiler, irrigation works construction, automobile and naval architecture, paper mill and mechanical industries. Company generates revenue from Sales of steel piping products. Products are exported to the United States, Mexico, Thailand, Singapore, Argentina, Taiwan, India, the Philippines, UAE and Canada. Geographically, majority revenue is generated from China.
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.